New HCV Drug Prospect Gets Good Marks for Safety
Already approved in the Russian Federation for treating Hepatitis B and C, NOV-205 has just demonstrated its safety in a U.S. Phase 1b trial. As we progress into 2008, look for reports on the efficacy of this drug.
Continue reading »